IT

Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.

Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.

Lab-grown milk is becoming commercially viable — and studies have shown that consumers aren’t averse to it. So, is it time for corporate investors to back these startups?

Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.

SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

Charbel Rizk has spun Oculi out of Johns Hopkins University to commercialise technology that gives computer vision the capabilities of the human eye.

These are the 55 women working in corporate venturing function across the DACH region — and how they got there.

Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.

SK has provided $50m in funding for Ascend Elements while ServiceNow took part in a $35.6m series C round for Fairmarkit.

Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.